R

Relmada Thera (RLMD)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Relmada Thera (RLMD)

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCa... Read more

  • 5.25
  • 5.44
  • 4.86
  • 38.68
  • -26.1%
  • --
  • 384.68k
  • 703.79k
  • 158M
  • 5.12
  • -73.1%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.